Specialized Prenatal Focus Sequenom Laboratories specializes in advanced prenatal genetic testing, which positions them as a key provider for obstetricians, geneticists, and maternal fetal medicine specialists. Engaging with these healthcare providers offers sales opportunities for related diagnostics, lab equipment, and data management solutions.

Innovative Technology Portfolio The company utilizes cutting-edge proprietary technologies like MaterniT™ and VisibiliT™, indicating a strong emphasis on technological innovation. Partnering for lab automation, bioinformatics tools, and data analysis solutions could enhance their diagnostic offerings and streamline their operations.

Strategic Industry Position Having been acquired by LabCorp and operating within a competitive biotech landscape, Sequenom's relationships with large industry players suggest opportunities for collaborations, licensing, or supply chain enhancements with other biotech and medical device companies.

Recent Product Expansion With the launch of expanded screening options like MaterniT Genome NIPS, Sequenom demonstrates a commitment to broadening its test offerings. This suggests potential for cross-selling related genetic testing products, extension services, and companion diagnostics to reach a wider market.

Moderate Revenue Potential Revenue estimates between $10 million and $25 million indicate room for growth. Introducing comprehensive solutions such as genetics data management platforms, sales channels for laboratory supplies, or complementary diagnostic products could unlock additional revenue streams and market share.